BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program
Go back to BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program| Bank of Commerce (NASDAQ: ONC) | Delayed: 380.37 +25.37 (7.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $355.00 | 52 Week High | $0.35 | |||
| Open | $380.00 | 52 Week Low | $0.35 | |||
| Day High | $383.00 | P/E | N/A | |||
| Day Low | $368.37 | EPS | $0.00 | |||
| Volume | 474,571 | |||||



